SPRB Spruce Biosciences, Inc.
$53.70▼ -1.20%
Healthcare
Other
After hours
$53.70▲ +0.00%
Sep 11, 7:30 PM ET
Volume 88.5K
Avg Volume (10D) 110.7K
Key Metrics & Fundamentals
Market Cap
$154.33M
P/E Ratio
–
Div Yield
–%
52W Range
7.26 - 240.00
% vs 50 MA
6.43%
% vs 200 MA
-14.20%
RSI-14
48.0
MACD Histogram
-0.8300
Beta (1Y vs SPY)
3.83
Free Cash Flow
-$22.26M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$15.12M
COGS
–
Operating Exp
$16.51M
Operating Income
-$16.51M
EBIT
-$16.51M
Pretax Income
-$16.23M
Net Income
-$16.23M
EPS (Diluted)
-6.68
Price & Volume History
Loading chart…
Recent News
Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Wire · Sep 8, 2026 8:05 PM
Spruce Biosciences stock gains after analyst backs regulatory progress
InvestorsHub · Aug 27, 2026 12:09 PM
Spruce Biosciences Announces Launch of MPS3BStudy.com
Business Wire · Aug 26, 2026 12:00 PM
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
Business Wire · Aug 24, 2026 12:00 PM
Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Business Wire · Aug 12, 2026 1:00 PM
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
Business Wire · Aug 12, 2026 12:00 PM
Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development
Business Wire · Aug 3, 2026 12:00 PM
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Business Wire · Jul 27, 2026 12:00 PM
American Express, Biogen upgraded: Wall Street's top analyst calls
The Fly · Jul 13, 2026 1:41 PM
B. Riley Initiates Spruce Biosciences at Buy With $160 Price Target
MT Newswires · Jul 13, 2026 12:28 PM
Financial Overview - Income Statement
Quarterly
Dec 2024
See SPRB's money flow as a full page
Social Sentiment
Avg +0.90 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.